ENTRY       D06563                      Drug
NAME        Belagenpumatucel-L (USAN);
            Lucanix (TN)
EFFICACY    Antineoplastic
  TYPE      Cellular therapy product
COMMENT     Allogeneic vaccine cocktail of TGF-beta blocked, whole non-small cell lung cancer tumor cells.
            Cell therapy treatment of non-small cell lung cancer
TARGET      TGFB2 [HSA:7042] [KO:K13376]
  PATHWAY   hsa04060(7042)  Cytokine-cytokine receptor interaction
            hsa04350(7042)  TGF-beta signaling pathway
            hsa05200(7042)  Pathways in cancer
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Transforming growth factors (RSTK-binding)
                TGFB2
                 D06563  Belagenpumatucel-L (USAN)
DBLINKS     PubChem: 47208219
///
